The management of paediatric allergy: Not everybodyÊs cup of tea - 10-11th February 2012

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue SUPPL.1, 2013, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ARABINOGALACTAN; BACTERIUM LYSATE; BECLOMETASONE DIPROPIONATE; BETA INTERFERON; BUDESONIDE; COLECALCIFEROL; CORTICOSTEROID; DEXAMETHASONE; ENDOTOXIN; FLUNISOLIDE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; FOOD ALLERGEN; GLUCOCORTICOID; GRASS POLLEN EXTRACT; HISTAMINE H1 RECEPTOR ANTAGONIST; HOUSE DUST ALLERGEN; INSECT VENOM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; OVALBUMIN; POLLEN ANTIGEN; PRO SYMBIOFLOR; PROBIOTIC AGENT; RAGWEED ANTIGEN; RECOMBINANT ALLERGEN; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY TEST; ALPHA HEMOLYTIC STREPTOCOCCUS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTIFICIAL MILK; ASTHMA; ATOPIC DERMATITIS; ATOPY; BREAST FEEDING; BRONCHUS HYPERREACTIVITY; CD4+ CD25+ T LYMPHOCYTE; CELL GRANULE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEST INFECTION; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; CYNODON DACTYLON; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; DIET THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EARLY INTERVENTION; ECZEMA; EGG ALLERGY; ENTEROCOCCUS FAECALIS; ENVIRONMENTAL CHANGE; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD ALLERGY; GENOTYPE ENVIRONMENT INTERACTION; GRASS; HAEMOPHILUS INFLUENZAE; HAY FEVER; HOUSE DUST ALLERGY; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFECTION PREVENTION; INFECTION RISK; INNATE IMMUNITY; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; LOW DRUG DOSE; LUNG FUNCTION; MACROPHAGE; MAST CELL; MATERNAL NUTRITION; MILK ALLERGY; MOLECULAR DIAGNOSIS; MORAXELLA CATARRHALIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; ORAL IMMUNOTHERAPY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEANUT ALLERGY; PERINATAL PERIOD; PERSONALIZED MEDICINE; PHLEUM PRATENSE; PRACTICE GUIDELINE; PRENATAL CARE; PRENATAL EXPOSURE; PRICK TEST; PRIMARY PREVENTION; PRIORITY JOURNAL; RECURRENT INFECTION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; REVIEW; SENSITIZATION; SKIN SENSITIZATION; SKIN TEST; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UNSPECIFIED SIDE EFFECT; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VITAMIN SUPPLEMENTATION; WHEEZING;

ALLERGENS; ANIMALS; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNITY, INNATE; INDIVIDUALIZED MEDICINE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84873599897     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835e8b94     Document Type: Review

References (430)

1. United Nations General Assembly. Prevention of NCDs in developing regions 2011. http://www.un.org/en/ga/ncdmeeting2011/. [Accessed 15 December 2012]
2. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry crosssectional surveys. Lancet 2006; 368:733-743. (Pubitemid 44279052)
3. Renz H, von Mutius E, Brandtzaeg P, et al. Gene-environment interactions in chronic inflammatory disease. Nat Immunol 2011; 12:273-277.
4. Robertson CF, Roberts MF, Kappers JH. Asthma prevalence in Melbourne schoolchildren: have we reached the peak? Med J Aust 2004; 180:273-276. (Pubitemid 38372231)
5. Warner JO. Anaphylaxis: The latest allergy epidemic. Pediatr Allergy Immunol 2007; 18:1-2.
6. Prescott SL, Allen K. Food Allergy: Riding the second wave of the allergy epidemic. Pediatr Allergy Immunol 2011; 22:155-160.
7. Mullins RJ. Paediatric food allergy trends in a community-based specialist allergy practice, 1995-2006. Med J Aust 2007; 186:618-621. (Pubitemid 47044681)
8. Boyce JA, Assaad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: Report of the NIAIDsponsored expert panel. J Allergy Clin Immunol 2010; 126:S1-S58.
9. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol 2011; 127:594-602.
10. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009; 124:1549-1555.
11. Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2010; 126:798-806.
12. Parham P. Innate immunity: The unsung heroes. Nature May 2003; 423:20.
13. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human Natural Killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223. (Pubitemid 32368034)
14. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NKcell cytokine and chemokine production by target cell recognition. Blood 2010; 115:2167-2176.
15. De Maria A, Bozzano F, Cantoni C, Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16 NK cells as rapid producers of abundant IFN-g on activation. PNAS 2011; 108:728-732.
16. Moretta L. Dissecting CD56dim human NK cells. Blood 2010; 116:3689-3691.
17. Moretta A, Bottino C, Pende D, et al. Identification of four subsets of human CD3-CD16 natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172:1589-1598.
18. Moretta A, Vitale M, Bottino C, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Antip58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993; 178:597-604. (Pubitemid 23218208)
19. Wei H, Zhang J, Xiao W, et al. Involvement of human natural killer cells in asthma pathogenesis: Natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 2005; 115:841-847. (Pubitemid 40460863)
20. Scordamaglia F, Balsamo M, Scordamaglia A, et al. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J All Clin Immunol 2008; 121:479-485. (Pubitemid 351222648)
21. Sivori S, Falco M, Della Chiesa M, et al. CpG and dsRNA trigger human NK cells via TLR. Induction of cytokine release and of cytolytic activity against tumors and immature dendritic cells. Proc Natl Acad Sci USA 2004; 101:10116-10121. (Pubitemid 38891204)
22. Marcenaro E, Della Chiesa M, Bellora F, et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 2005; 174:3992-3998. (Pubitemid 40395974)
23. Liew FY, Xu D, Brint EK, ONeill LA. Negative regulation of Toll-like receptormediated immune responses. Nat Rev Immunol 2005; 5:446-458. (Pubitemid 40835033)
24. Prescott SL, Nowak-Wȩgrzyn A. Strategies to prevent or reduce allergic disease. Ann Nutr Metab 2011; 59:28-42.
25. Prescott S, Macaubas C, Smallacombe T, et al. Development of allergenspecific T-cell memory in atopic and normal children. Lancet 1999; 353: 196-200. (Pubitemid 29088031)
26. Tulic M, Forsberg A, Hodder M, et al. Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny. J Allergy Clin Immunol 2011; 127:470-478.
27. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120:1413-1417. (Pubitemid 350216612)
28. Osborne NJ, Koplin JJ, Martin PE, et al. Prevalence of challenge-proven IgEmediated food allergy using a population-based sampling frame and predetermined challenge criteria in infants. J Allergy Clin Immunol 2011; 127:668-676.
29. Tariq SM, Matthews SM, Hakim EA, Arshad SH. Egg allergy in infancy predicts respiratory allergic disease by 4 years of age. Pediatr Allergy Immunol 2000; 11:162-167. (Pubitemid 30666556)
30. Prescott SL, Smith P, Tang MLK, et al. The importance of early complementary feeding in the development of oral tolerance: Concerns and controversies. Pediatr Allergy Immunol 2008; 19:375-380. (Pubitemid 351989325)
31. Szepfalusi Z, Loibichler C, Hanel-Dekan S, et al. Most of diaplacentally transferred allergen is retained in the placenta. Clin Exp Allergy 2006; 36:1130-1137. (Pubitemid 44342927)
32. Szepfalusi Z, Loibichler C, Pichler J, et al. Direct evidence for transplacental allergen transfer. Pediatr Res 2000; 48:404-407. (Pubitemid 30637345)
33. Dahl GM, Telemo E, Westrom BR, et al. The passage of orally fed proteins from mother to fetus in the rat. Comp Biochem Physiol 1984; 77A:199-201. (Pubitemid 14159709)
34. Holloway JA, Warner JO, Vance GH, et al. Detection of house-dust-mite allergen in amniotic fluid and umbilical-cord blood. Lancet 2000; 356:1900-1902.
35. Michaelsson J, Mold JE, McCune JM, Nixon DF. Regulation of T cell responses in the developing human fetus. J Immunol 2006; 176:5741-5748.
36. Mold JE, Michaelsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-1565.
37. Mold JE, Venkatasubrahmanyam S, Burt TD, et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 2010; 330:1695-1699.
38. Mold JE, McCune JM. At the crossroads between tolerance and aggression: Revisiting the layered immune system hypothesis. Chimerism 2011; 2:35-41.
39. Mackroth MS, Malhotra I, Mungai P, et al. Human cord blood CD4CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens. J Immunol 2011; 186:2780-2791.
40. Thornton CA, Upham JW, Wikstrom ME, et al. Functional maturation of CD4CD25CTLA4CD45RA T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J Immunol 2004; 173:3084-3092. (Pubitemid 39142014)
41. Prescott S, Macaubas C, Holt B, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses towards Th-2 cytokine profile. J Immunol 1998; 160:4730-4737. (Pubitemid 28215305)
42. Jones A, Miles E, Warner J, et al. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996; 7:109-116. (Pubitemid 27042613)
43. Smith M, Tourigny MR, Noakes P, et al. Children with egg allergy have evidence of reduced neonatal CD4()CD25()CD127(lo/-) regulatory T cell function. J Allergy Clin Immunol 2008; 121:1460-1466.
44. Vance GH, Lewis SA, Grimshaw KE, et al. Exposure of the fetus and infant to hens egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg. Clin Exp Allergy 2005; 35:1318-1326.
45. Marks GB, Zhou J, Yang HS, et al. Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy 2002; 32:355-360. (Pubitemid 34415633)
46. Smillie FI, Elderfield AJ, Patel F, et al. Lymphoproliferative responses in cord blood and at one year: No evidence for the effect of in utero exposure to dust mite allergens. Clin Exp Allergy 2001; 31:1194-1204. (Pubitemid 34208957)
47. Vance GH, Grimshaw KE, Briggs R, et al. Serum ovalbumin-specific immunoglobulin G responses during pregnancy reflect maternal intake of dietary egg and relate to the development of allergy in early infancy. Clin Exp Allergy 2004; 34:1855-1861. (Pubitemid 40023635)
48. Lange H, Kiesch B, Linden I, et al. Reversal of the adult IgE high responder phenotype in mice by maternally transferred allergen-specific monoclonal IgG antibodies during a sensitive period in early ontogeny. Eur J Immunol 2002; 32:3133-3141. (Pubitemid 35414871)
49. Matzinger P, Kamala T. Tissue-based class control: The other side of tolerance. Nat Rev Immunol 2011; 11:221-230.
50. West CE, Videky D, Prescott SL. Role of diet in the development of immune tolerance in the context of allergic disease. Curr Opin Pediatr 2010; 22:635-641.
51. Noakes PS, Hale J, Thomas R, et al. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J 2006; 28:721-729. (Pubitemid 46331991)
52. Noakes PS, Holt PG, Prescott SL. Maternal smoking in pregnancy alters neonatal cytokine responses. Allergy 2003; 58:1053-1058. (Pubitemid 37260350)
53. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharideexposure prevents allergic sensitisation and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005; 35:397-402. (Pubitemid 40516669)
54. Blumer N, Sel S, Virna S, et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 2007; 37:348-357. (Pubitemid 46393247)
55. Brand S, Teich R, Dicke T, et al. Epigenetic regulation of in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes. J Allergy Clin Immunol 2011; 128:618-625.
56. Martino D, Prescott SL. Epigenetics and prenatal influences on asthma and allergic airways disease. Chest 2011; 139:640-647.
57. Macaubas C, de Klerk NH, Holt BJ, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 2003; 362:1192-1197. (Pubitemid 37255345)
58. Tulic MK, Andrews D, Crook ML, et al. Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J Allergy Clin Immunol 2012; 129:199-206.
59. Watanabe N, Hanabuchi S, Soumelis V, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4 T cell homeostatic expansion. Nat Immunol 2004; 5:426-434. (Pubitemid 38500092)
60. Watanabe N, Wang YH, Lee HK, et al. Hassalls corpuscles instruct dendritic cells to induce CD4CD25 regulatory T cells in human thymus. Nature 2005; 436:1181-1185. (Pubitemid 41232298)
61. Mazzucchelli R, Hixon JA, Spolski R, et al. Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood 2008; 112:3283-3292.
62. Jiang Q, Su H, Knudsen G, et al. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: Role of TSLP. Immunology 2006; 7:6.
63. Palmer DJ, Gold MS, Makrides M. Effect of maternal egg consumption on breast milk ovalbumin concentration. Clin Exp Allergy 2008; 38:1186-1191.
64. Mosconi E, Rekima A, Seitz-Polski B, et al. Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunol 2010; 3:461-474.
65. Macchiaverni P, Arslanian C, Frazao JB, et al. Mother to child transfer of IgG and IgA antibodies against Dermatophagoides pteronyssinus. Scand J Immunol 2011; 74:619-627.
66. Prentice AM, Collinson AC. Does breastfeeding increase thymus sizȩActa Paediatr 2000; 89:8-12. (Pubitemid 30060621)
67. Aspinall R, Prentice AM, Ngom PT. Interleukin 7 from maternal milk crosses the intestinal barrier and modulates T-cell development in offspring. PLoS One 2011; 6:6 e20812.
68. Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008;121:1331-1336. (Pubitemid 351787358)
69. Fallon PG, Sasaki T, Sandilands A, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41:602-608.
70. Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Investig Dermatol 2009; 129:1892-1908.
71. Hill DJ, Sporik R, Thorburn J, Hosking CS. The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. J Pediatr 2000; 137:475-479.
72. Prescott SL, Clifton VL. Asthma and pregnancy: emerging evidence of epigenetic interactions in utero. Curr Opin Allergy Clin Immunol 2009; 9:417-426.
73. Haddeland U, Karstensen AB, Farkas L, et al. Putative regulatory T cells are impaired in cord blood from neonates with hereditary allergy risk. Pediatr Allergy Immunol 2005; 16:104-112.
74. Kuehr J, Frischer T, Meinert R, et al. Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994; 94:44-52. (Pubitemid 24219658)
75. Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clinical Immunol 1997; 99:763-769. (Pubitemid 27280366)
76. Arshad SH, Tariq SM, Matthews SM, Hakim EA. Sensitization to common allergens and its association with allergic disorders at age 4 years: A whole population birth cohort study. Pediatrics 2001; 108:e33.
77. Arshad SH, Matthews S, Gant C, Hide DW. Effect of allergen avoidance on development of allergic disorders in infancy. The Lancet 1992; 339:1493-1497.
78. Arshad SH, Bateman B, Sadeghnejad A, et al. Prevention of allergic disease during childhood by allergen avoidance: The Isle of Wight prevention study. J Allergy Clin Immunol 2007; 119:307-313. (Pubitemid 46210081)
79. Horak F, Matthews S, Ihorst G, et al. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study: 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy 2004; 34:1220-1225. (Pubitemid 39093060)
80. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995; 95:1179-1190.
81. Maas T, Dompeling E, Muris JW, et al. Prevention of asthma in genetically susceptible children: A multifaceted intervention trial focussed on feasibility in general practice. Pediatr Allergy Immunol 2011; 22:794-802.
82. Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008; 122:984-991.
83. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year followup on the PAT study. Allergy 2007; 62:943-948. (Pubitemid 47037870)
84. Alexander DD. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: A meta-analysis. J Pediatr Gastroenterol Nutr 2010; 50:422-430.
85. Szajewska H. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010; 26:423-437.
86. Osborn D, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. 2007; 4:CD003664.
87. von Berg A, Filipiak-Pittroff B, Krãmer U, et al., GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: Long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121:1442-1447. (Pubitemid 351787357)
88. Pichler J, Gerstmayr M, Szepfalusi Z, et al. 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 2002; 52:12-18. (Pubitemid 34665944)
89. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59:469-478. (Pubitemid 38580764)
90. Gale CR, Robinson SM, Harvey NC, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J of Clin Nutrition 2008; 62:68-77.
91. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 years of age. Am J Clin Nutr 2007; 85:788-795. (Pubitemid 46393511)
92. Devereux G, Litonjua AA, Turner SW, et al. Ma ternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007; 85:853-859. (Pubitemid 46393519)
93. Weiss ST, Litonjua AA. Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases. Thorax 2007; 62:746-748.
94. Harvey NC, Javaid K, Bishop N, et al. MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study Group. Trials 2012; 13:13.
95. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-672.
96. Arshad SH, Kurukulaaratchy RK, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma and bronchial hyper-responsiveness at 10-years of age. Chest 2005; 127:502-508. (Pubitemid 40229309)
97. Dharmage SC, Erbas B, Jarvis D, et al. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur Respir J 2009; 33: 237-244.
98. Wark PA, Johnston HL, Bucchieri F, et al. Asthmatic bronchial epithelial cellshave a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-947. (Pubitemid 40524463)
99. Razi CH, Harmanci K, Abaci A, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010; 126:763-769.
100. Braun-Fahrlãnder C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-877.
101. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming early life and its development of asthma and allergy: A cross-sectional survey. Lancet 2001; 358:1129-1133. (Pubitemid 32971845)
102. Conrad ML, Ferstl R, Teich R, et al. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Experim Med 2009; 206:2869-2877.
103. Loss G, Apprich S, Waser M, et al. The protective effect of farm milk consumption on childhood asthma and atopy: The GABRIELA study. J Allergy Clin Immunol 2011; 128:766-773.
104. Peters M, Kauth M, Scherner O, et al. Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization. J Allergy Clin Immunol 2010; 126:648-656.
105. Gerhold K, Avagyan A, Seib C, et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 2006; 118:666-673. (Pubitemid 44301398)
106. Ahrens B, Quarcoo D, Buhner S, et al. Oral administration of bacterial lysates attenuates experimental food allergy. Int Arch Allergy Immunol 2011; 156:196-204.
107. Navarro S, Cossalter G, Chiavaroli C, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory cells to the airways. Mucosal Immunol 2011; 4:53-65.
108. Johannsen H, Prescott SL. Practical prebiotics, probiotics, synbiotics for allergists: how useful are they? Clin Exp Allergy 2009; 39:1801-1814.
109. Lau S, Gerhold K, Zimmermann K, et al. Oral application of bacterial lysate in infancy decreases the risk of infantile atopic eczema in a subgroup of children with paternal atopy. J Allergy Clin Immunol 2012; 129:1040-1047.
110. Pawankar R, Canonica GW, Holgate ST, Lockey RF, eds. WAO White Book on Allergy. Milwaukee, WI: World Allergy Organization; 2011:1-216.
111. Gupta RS, Springston EE, Kim JS, et al. Food allergy knowledge, attitudes, and beliefs of primary care physicians. Pediatrics 2010; 125:126-132.
112. Jaeschke R, Guyatt GH, Dellinger P, et al. GRADE Working Group. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008; 337:a744.
113. Venter C, Arshad SH. Guideline fever: An overview of DRACMA, US NIAID and UK NICE guidelines. Curr Opin Allergy Clin Immunol 2012; 12:302-315.
114. Fiocchi A, Brozek JL, Schũnemann HJ, et al. World allergy organization (WAO) diagnosis and rationale for action against cows milk allergy (DRACMA) guidelines. World Allergy Organization (WAO) Journal 2010; 3:1-161.
115. National Institute for Health and Clinical Excellence. Diagnosis and assessment of food allergy in children and young people in primary care and community settings. http://guidance.nice.org.uk. Guideline no. CG116 2011; pp. 1-28.
116. van der Weijden T, Boivin A, Burgers J, et al. Clinical practice guidelines and patient decision aids: An inevitable relationship. J Clin Epidemiol 2012; 65:584-589.
117. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cows milk allergy: A systematic review and meta-analysis. Clin Exp Allergy 2012; 42:363-374.
118. Terracciano L, Brozek J, Compalati E, Schũnemann H. GRADE system: New paradigm. Curr Opin Allergy Clin Immunol 2010; 10:377-383.
119. Terracciano L, Schũnemann H, Brozek J, et al., on behalf of the DRACMA Implementation Committee, World Allergy Organisation. How DRACMA changes clinical decision for the individual patient in CMA therapy. Curr Opin Allergy Clin Immunol 2012; 12:316-322.
120. Mallol J, Crane J, von Mutius E, et al. the ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis. Allergol Immunopathol (Madr). 2012 Jul 6. [Epub ahead of print]
121. Valovirta E, Pawankar R. Survey on the impact of comorbid allergic rhinitis in patients with asthma. BMC Pulm Med 2006; 6 (Suppl 1):S3.
122. Crystal-Peters J, Neslusan C, CrownWH, Torres A. Treating allergic rhinitis in patientswith comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57-62. (Pubitemid 34112130)
123. Stelmach R, do Patrocínio T, Nunes M, et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma.Chest 2005; 128:3140-3147. (Pubitemid 41698633)
124. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109:251-256. (Pubitemid 34158289)
125. Bateman ED, Boushey HA, Bousquet J, et al., GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836-844. (Pubitemid 39346477)
126. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl 5):S147-334.
127. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact onasthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(suppl).
128. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126:466-476.
129. Schafer T, Schnoor M, Wagenmann M, et al. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Rhinology 2011; 49:272-280.
130. Simons FE, Ardusso LR, Bilò MB, et al., for the World Allergy Organization. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12:389-399.
131. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426.
132. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO Guideline: management of urticaria. Allergy 2009; 64:1427-1443.
133. Canonica GW, Bousquet J, Casale T, et al. Sublingual immunotherapy: World Allergy Organization Position Paper 2009. World Allergy Organization Journal 2009; 2:223-281.
134. Cox L, Larenas-Linnemann D, Lockey R, et al. Speaking the same language: The World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol 2010; 125:569-574.
135. Casale TB, Canonica GW, Bousquet J, et al. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol 2009; 124:665-670.
136. Lotvall J, Pawankar R, Wallace DV, et al. We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. World Allergy Organ J 2012; 5:39-40.
137. Popov TA, Ledford D, Lockey RF, et al. Maintenance of skills, competencies, and performance in allergy and clinical immunology: Time to lay the foundation for a universal approach. World Allergy Organ J 2012; 5:45-51.
138. DAmato G, Rottem M, Dahl R, et al., for the WAO Special Committee on Climate Change and Allergy. Climate change, migration, and allergic respiratory diseases: An update for the allergist. World Allergy Organ Jl 2011; 4:121-125.
139. Simons FE. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergyimmunology specialists in healthcare settings. Ann Allergy Asthma Immunol 2010; 104:405-412.
140. Kanny G, Moneret-Vautrin DA, Flabbee J, et al. Population study on food allergy in France. J Allergy Clin Immunol 2001; 108:133-140. (Pubitemid 32662245)
141. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113:805-819. (Pubitemid 38608586)
142. Venter C, Pereira B, Voigt K, et al. Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy 2008; 63:354-359. (Pubitemid 351224676)
143. Ostblom E, Lilja G, Pershagen G, et al. Phenotypes of food hypersensitivity and development of allergic diseases during the first 8 years of life. Clin Exp Allergy 2008; 38:1325-1332. (Pubitemid 352019664)
144. Pereira B, Venter C, Grundy J, et al. Prevalence of sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers. J Allergy Clin Immunol 2005; 116:884-892. (Pubitemid 41400556)
145. Jansen JJ, Kardinaal AF, Huijbers G, et al. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994; 93:446-456. (Pubitemid 24081785)
146. Woods RK, Abramson M, Bailey M, Walters EH. International prevalences of reported food allergies and intolerances. Comparisons arising from the European Community Respiratory Health Survey (ECRHS). Eur J Clin Nutr 2001; 55:298-304. (Pubitemid 32266522)
147. Grundy J, Matthews S, Bateman B, et al. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol 2002; 110:784-789. (Pubitemid 35423183)
148. Burks AW, Mallory SB, Williams LW, Shirrell MA. Atopic dermatitis: Clinical relevance of food hypersensitivity reactions. J Pediatr 1988; 113:447-451.
149. Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101:e8.
150. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108:861-866. (Pubitemid 33096222)
151. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: A population based study. J Allergy Clin Immunol 1999; 104:452-456. (Pubitemid 29420446)
152. Onorato J, Merland N, Terral C, et al. Placebo-controlled double-blind food challenge in asthma. J Allergy Clin Immunol 1986; 78:1139-1146. (Pubitemid 17227459)
153. Novembre E, de Martino M, Vierucci A. Foods and respiratory allergy. J Allergy Clin Immunol 1988; 81:1059-1065.
154. James JM, Eigenmann PA, Eggleston PA, Sampson HA. Airway reactivity changes in asthmatic patients undergoing blinded challenges. Am J Respir Crit Care Med 1996; 153:597-603. (Pubitemid 26051334)
155. Host A, Halken S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life: Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy 1990; 45:587-596. (Pubitemid 20376302)
156. Schrander JJ, van den Bogart JP, Forget PP, et al. Cows milk protein intolerance in infants under 1 year of age: A prospective epidemiological study. Eur J Pediatr 1993; 152:640-644. (Pubitemid 23211146)
157. Kvenshagen B, Halvorsen R, Jacobsen M. Adverse reactions to milk in infants. Acta Paediatr 2008; 97:196-200. (Pubitemid 351197953)
158. Nickel R, Kuliq M, Forster J, et al. Sensitization to hens egg at the age of twelve months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997; 99:613-617. (Pubitemid 27213187)
159. Sicherer SH, Muñoz-Furlong A, Sampson HA. Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol 2004; 114:159-165. (Pubitemid 39005133)
160. Sicherer SH, Muñoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: A 5 year follow-up study. J Allergy Clin Immunol 2003; 112:1203-1207. (Pubitemid 37550017)
161. van Odijk J, Ahlstedt S, Bengtsson U, et al. Specific IgE antibodies to peanut in western Sweden: has the occurrence of peanut allergy increased without an increase in consumption? Allergy 2001; 56:573-577. (Pubitemid 32521443)
162. Tariq SM, Stevens M, Matthews S, et al. Cohort study of peanut and tree nut sensitization by age of 4 years. BMJ 1996; 313:514-517. (Pubitemid 26336132)
163. Sicherer SH, Muñoz-Furlong A, Burks AW, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random
164. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 2011; 128:e9-e17.
165. Branum AM, Lukacs SL. Food allergy among U.S. children: Trends in prevalence and hospitalizations. NCHS Data Brief 2008; 10:1-8.
166. Prescott SL. Allergy: The price we pay for cleaner living. Ann Allergy Asthma Immunol 2003; 90:64-70. (Pubitemid 36763495)
167. von Mutius E. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: farm lifestyles and the hygiene hypothesis. Clin Exp Immunol 2010; 150:130-135.
168. Bahna SL. Adverse food reactions by skin contact. Allergy 2004; 59:66-70. (Pubitemid 39005850)
169. Ramirez DA Jr, Bahna SL. Food hypersensitivity by inhalation. ClinMol Allergy 2009; 7:4.
170. Kaza U, Knight AK, Bahna SL. Risk factors for the development of food allergy. Curr Allergy Asthma Rep 2007; 7:182-186. (Pubitemid 46784196)
171. Chochrane S, Beyer K, Clausen M, et al. Factors influencing the incidence and prevalence of food allergy. Allergy 2009; 64:1246-1255.
172. Untersmayr E, Poulsen LK, Platzer MH, et al. The effects of gastric digestion on codfish allergenicity. J Allergy Clin Immunol 2005; 115:377-382. (Pubitemid 40215107)
173. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol 2008; 121:1031-1038.
174. Untersmayr E, Scholl I, Swoboda I, et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: A fish allergy model in BALB/ c mice. J Allergy Clin Immunol 2003; 112:616-623. (Pubitemid 37108569)
175. Schöll I, Untersmayr E, Bakos N, et al. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans. Am J Clin Nutr 2005; 81:154-160. (Pubitemid 43073389)
176. Untersmayr E, Bakos N, Schöll I, et al. Antiulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J 2005; 19:656-658. (Pubitemid 40471276)
177. Long K, Santos J. Vitamins and the regulation of the immune response. Pediatr Infect Dis J 1999; 18:283-290. (Pubitemid 29128381)
178. Li-Weber M, Giaisi M, Treiber MK, Krammer PH. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol 2002; 32:2401-2408.
179. Hoag KA, Nashold FE, Goverman J, Hayes CE. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J Nutr 2002; 132:3736-3739. (Pubitemid 35435055)
180. Milner JD, Stein DM, McCarter R, Moon RY. Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma. Pediatrics 2004; 114:27-32. (Pubitemid 38857562)
181. Mullins RJ, Camargo CA Jr. Shining a light on vitamin D and its impact on the developing immune system. Clin Exp Allergy 2011; 41:766-768
182. Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: A metaanalysis. J Allergy Clin Immunol 2007; 120:638-646.
183. Mills ENC, Mackie AR, Burney P, et al. The prevalence, cost and basis of food allergy across Europe. Allergy 2007; 62:717-722. (Pubitemid 46934378)
184. Kummeling I, Mills ENC, Clausen M, et al. The EuroPrevall surveys on the prevalence of food allergies in children and adults: Background and study methodology. Allergy 2009; 64:1493-1497.
185. Wong GW, Mahesh PA, Ogorodova L, et al. The EuroPrevall-INCO surveys on the prevalence of food allergies in children from China, India and Russia: The study methodology. Allergy 2010; 65:385-390.
186. Keil T, McBride D, Grimshaw K, et al. The multinational birth cohort of EuroPrevall: Background, aims and methods. Allergy 2010; 65:482-490.
187. McBride D, Keil T, Grabenhenrich L, et al. The EuroPrevall birth cohort study on food allergy: Baseline characteristics of 12 000 newborns and their families from nine European countries. Pediatr Allergy Immunol 2012; 23:230-239.
188. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124 (Suppl 3):S43-S70.
189. Golbin A, Bernales R, Lin DT. Perennial allergic rhinitis and sleep disorders. Ann Allergy 1992; 68:85.
190. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 2004; 114 (Suppl 5):S139-S145. (Pubitemid 39440925)
191. Stuck BA, Czajkowski J, Hagner AE, et al. Changes in daytime sleepiness,quality of life, and objective sleep patterns in seasonal allergic rhinitis: A controlled clinical trial. J Allergy Clin Immunol 2004; 113:663-668. (Pubitemid 38530420)
192. Kuiper S, Muris JWM, Dompeling E, et al. Interactive effect of family history and environmental factors on respiratory tract-related morbidity in infancy. J Allergy Clin Immunol 2007; 120:381-387.
193. Allergies in America: A landmark survey of nasal allergy sufferers: Executive Summary, 2006. Florham Park, NJ: Altana Pharma US; 2006. Available at http://www.worldallergy.org/allergic-rhinitis/resources/surveyfindings/
194. Gadkari AS, McHorney CA. Medication nonfulfillment rates and reasons: Narrative systematic review. Curr Med Res Opin 2010; 26:663-705.
195. Matsui D. Current issues in pediatric medication adherence. Paeditr Drugs 2007; 9:283-288. (Pubitemid 47557110)
196. Tarn DM, Heritage J, Paterniti DA, et al. Physician communication when prescribing new medications. Arch Intern Med 2006; 166:1855-1862. (Pubitemid 44455168)
197. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: Clinical applications. JAMA 2002; 288:2880-2883. (Pubitemid 35425074)
198. Auffray C, Adcock IM, Chung KF, et al. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137:1410-1416.
199. Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-1495. (Pubitemid 47572634)
200. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5:e8578.
201. Bracken MB, Fleming L, Hall P, et al. The importance of nurse led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009; 94:780-784.
202. Bush A, Saglani S. Management of severe asthma in children. Lancet 2010; 376:814-825.
203. Sharples J, Gupta A, Fleming L, et al. Long-term effectiveness of a staged assessment for problematic severe asthma. Eur Respir J 2012; 40:264-278.
204. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112-1117.
205. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: A systematic review with meta-analysis. Pediatrics 2009; 123:e519-e525.
206. Marinho S, Simpson A, Söderström L, et al. Quantification of atopy and the probability of rhinitis in preschool children: A population-based birth cohort study. Allergy 2007; 62:1379-1386. (Pubitemid 350045590)
207. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: An evidence-based approach. Eur Respir J 2008; 32:1096-1110.
208. Sonnappa S, Bastardo CM, Saglani S, et al. Relationship between past airway pathology and current lung function in preschool wheezers. Eur Respir J 2011; 38:1431-1436.
209. Harris JM, Bush A, Wilson N, et al. Preschool wheezing phenotypes in a representative school cohort. Thorax 2010; 65 (Suppl 4):A37.
210. Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: A randomised controlled trial. Am J Respir Crit Care Med 2007; 175:323-329.
211. Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011; 365:1990- 2001.
212. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-224.
213. Cartledge N, Brown S, Bossley C, et al. Is a single intramuscular dose of triamcinolone and acute bronchodilator sufficient to determine optimal lung function in children with severe, therapy resistant asthma? Thorax 2011; 66 (Suppl 4):A101-A102.
214. Moore WC, Bleecker ER, Curran-Everett D, et al., National Heart, Lung, Blood Institutes Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institutes Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-413. (Pubitemid 46210080)
215. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22:470-477.
216. Bossley CJ, Fleming L, Gupta A, et al. Paediatric severe asthma is characterized by eosinophilia and remodelling without Th2 cytokines. J Allergy Clin Immunol 2012; 129:974-982.
217. Fitzpatrick AM, Teague WG, Meyers DA, et al., National Institutes of Health/ National Heart, Lung, and Blood Institute Severe Asthma Research Program. Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011; 127:382-389.
218. Fitzpatrick AM, Higgins M, Holguin F, et al., National Institutes of Health/ National Heart, Lung, and Blood Institutes Severe Asthma Research Program. The molecular phenotype of severe asthma in children. J Allergy Clin Immunol 2010; 125:851-857.
219. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-984.
220. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisonedependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-993.
221. Fleming L, Tsartsali L, Wilson N, et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax 2012; 67:675-681.
222. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113:101-108. (Pubitemid 38096168)
223. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyperresponsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: A longitudinal birth-cohort study. Lancet 2008; 372:1058-1064.
224. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function.N Engl J Med 1998; 338:581-587. (Pubitemid 28114646)
225. Wark PA, Simpson J, Hensley MJ, Gibson PG. Airway inflammation in thunderstorm asthma. Clin Exp Allergy 2002; 32:1750-1756. (Pubitemid 35463861)
226. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61:376-382. (Pubitemid 43723318)
227. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-1063.
228. Innes AL, McGrath KW, Dougherty RH, et al. The H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbation. Am J Respir Crit Care Med 2011; 183:189-194.
229. Martin AC, Laing IA, Khoo SK, et al. Acute asthma in children: Relationships among CD14 and CC16 genotypes, plasma levels, and severity. Am J Respir Crit Care Med 2006; 173:617-622. (Pubitemid 43363802)
230. Haselkorn T, Zeiger RS, Chipps BE, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2009; 124:921-927.
231. Haselkorn T, Fish JE, Zeiger RS, et al., TENOR Study Group. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009; 124:895-902.
232. Fleming L, Wilson N, Regamey N, Bush A. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012; 67:193-198.
233. Bel EH, Souza A, Fleming L, et al. Diagnosis and definition of severerefractory asthma: An international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66:910-917. UBIOPRED consensus document on the definition of severe asthma, intended for international use
234. Hedlin G, Bush A, Lødrup Carlsen K, et al., on behalf of the Problematic Severe Asthmain Childhood Initiative group. Problematic severe asthma in children, not one problem but many: A GA2LEN initiative. Eur Respir J 2010; 36:196-201.
235. Lødrup Carlsen KC, Hedlin G, Bush A, et al., on behalf of the PSACI (Problematic Severe Asthma in Childhood Initiative) group. Assessment of problematic severe asthma in children. Eur Respir J 2011; 37:432-440.
236. Bush A, Pedersen S, Hedlin G, et al., On behalf of the PSACI group. Pharmacological treatment of severe, therapy resistant asthma in children: what can we learn from wherȩEur Respir J 2011; 38:947-958. Comprehensive review of beyond guidelines asthma therapy in children, highlighting the lack of evidence in the field
237. Weber RW. Potency variability in diagnostic allergen extracts: Is there an optimal strength? Ann Allergy Asthma Immunol 2011; 106:353-354.
238. Larenas-Linneman D, Esch RE, Guidos-Fogelbach G, Rodriguez-Pèrez N. A comparison of in vitro potency between European and Mexican allergen extracts and US (CBER/FDA) reference extracts. Allergol Immunopathol (Madr) 2010; 38:170-173.
239. Larenas-Linnemann D, Matta JJ, Shah-Hosseini K, et al. Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United States. Ann Allergy Asthma Immunol 2010; 104:420-425.
240. Larenas-Linnemann D, Cruz AA, Gutierrez IR, et al. Some European and Mexican diagnostic extracts of Bermuda grass and cat less potent in skintesting than US extracts. Ann Allergy Asthma Immunol 2011; 106:421-428.
241. Rackemann FM, Simon FA. Technic on intracutaneous tests and results of routine tests in normal persons. J Allergy 1934; 5:184-188.
242. Lindblad JH, Farr RS. The incidence of positive intradermal reactions and the demonstration of skin sensitizing antibody to extracts of ragweed and dust in humans without history of rhinitis or asthma. J Allergy 1961; 32:392-401.
243. Reisman RE. Diagnostic venom skin tests and venom specific IgE assays: do we need to worry? Ann Allergy Asthma Immunol 2006; 96:5-6. (Pubitemid 43152660)
244. Lavins BJ, Dolen WK, Nelson HS, Weber RW. Use of standardized and conventional allergen extracts in prick skin testing. J Allergy Clin Immunol 1992; 89:658-666.
245. Larenas-Linnemann D, Cox LS, Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology. European allergen extract units and potency: Review of available information. Ann Allergy Asthma Immunol 2008; 100:137-145. (Pubitemid 351238549)
246. Pastorello EA, Incorvaia C, Ortolani C, et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic allergy to common aeroallergens. J Allergy Clin Immunol 1995; 96:580-587.
247. Zarei M, Remer CF, Kaplan MS, et al. Optimal skin prick wheal size for diagnosis of cat allergy. Ann Allergy Asthma Immunol 2004; 92:604-610. (Pubitemid 39243149)
248. Peters RL, Gurrin LC, Allen KJ. The predictive value of skin prick testing for challenge-proven food allergy: A systematic review. Pediatr Allergy Immunol 2012; 23:347-352.
249. Kleine-Tebbe J, Ballmer-Weber B, Beyer K, et al. In vitro diagnostics and molecular basis of IgE-mediated food allergies [in German]. Allergo J 2009; 18:132-146.
250. Hoffmann-Sommergruber K, Mills EN, Vieths S. Coordinated and standardized production, purification and characterization of natural and recombinant food allergens to establish a food allergen library. Mol Nutr Food Res 2008; 52 (Suppl 2):S159-S165.
251. Mattson L, DeWitt AM, Gubesch M, et al. Recombinant Gly m 4, a useful reagent in the investigation of birch pollen associated soybean allergy. XXV Congress of the European Acad Allergol Clin Immunol, 10-14 June 2006, Vienna, Austria
252. Holzhauser T, Wackermann O, Ballmer-Weber BK, et al. Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. J Allergy Clin Immunol 2009; 123:452-458.
253. Ito K, Sjölander S, Sato S, et al. IgE to Gly m 5 and Gly m 6 is associated with severe allergic reactions to soybean in Japanese children. J Allergy Clin Immunol 2011; 128:673-675.
254. Hansen KS, Ballmer-Weber BK, Sastre J, et al. Component-resolved in vitro diagnosis of hazelnut allergy in Europe. J Allergy Clin Immunol 2009; 123:1134-1141.
255. Beyer K, Grishina G, Bardina L, et al. Identification of an 11S globulin as a major hazelnut food allergen in hazelnut-induced systemic reactions. J Allergy Clin Immunol 2002; 110:517-523.
256. Finegold I, Dockhorn RJ, Ein D, et al. Immunotherapy throughout the decades: from Noon to now. Ann Allergy Asthma Immunol 2010; 105:328-336.
257. Cooke RA, Vander Veer A. Human sensitization. J Immunol 1916; 1:201-305.
258. Spain WC, Cooke RA, Studies in specific hypersensitiveness XI. The familial occurrence of hay fever and bronchial asthma. J Immunol 1924; 9:521.
259. Tuft L. Clinical Allergy. Philadelphia: WB Saunders Company; 1938. p. 180
260. Cook RA. Allergy in Theory and Practice. Philadelphia: WB Saunders Company; 1947. p. 204.
261. Finegold I. Immunotherapy: when to initiate treatment in children. Allergy Asthma Proc 2007; 28:698-705.
262. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: A 14-year study. Pediatrics 1968; 42:793-802.
263. Adkinson N, Eggleston PA, Eney D, et al. A Controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997; 336:324-332.
264. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997; 336:1356-1363. (Pubitemid 27208619)
265. Esch RE. Allergen immunotherapy: what can and cannot be mixed? J Allergy Clin Immunol 2008; 122:659-660.
266. Joint Task Force On Practice Parameter. Allergen immunotherapy: A practice parameter. Ann Allergy Asthma Immunol 2003; 90(Suppl 1):S1-S40.
267. Cox L, Li JT, Nelson H, Lockey R. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 2007; 120:S25-S85. (Pubitemid 47313519)
268. Cox L, Li J, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 2011; 127 (Suppl 1):S1-S55.
269. Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaidenrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008; 121:227-233.
270. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and healthcare cost benefits for children with allergic rhinitis: A large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 2010; 104:79-85.
271. Rabin R. Report on the safety of nonstandardized allergenic extracts. October 25, 2011. ucm282868 wwwfda.gov/AdvisoryCommittees/Committees- MeetingMaterials/BloodVaccinesandOtherBiologics/ AllergenicProductsAdvisoryCommit aconato H Petee/ucm282868.htm
272. Bernstein DI, Epstein T. Systemic reactions to subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 2011; 31:241-249.
273. Bernstein D. Presentation at ACAAI Annual Meeting Nov 2011.
274. Scadding GK, Brostoff J. Low dose sublingual immunotherapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16:483-491. (Pubitemid 16006675)
275. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010; 8:CD001186.
276. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: A meta-analysis of randomized, placebo-controlled, doubleblind trials. Ann Allergy Asthma Immunol 2006; 97:141-148. (Pubitemid 44272577)
277. Penagos M, Passalacqua G, Compalati E, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2007; 133:599-609.
278. Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010; 12:CD002893.
279. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; 2:CD002893.
280. Calamita Z, Saconato H, Pelà AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trias using the Cochrane Collaboration Method. Allergy 2006; 61:1162-1172. (Pubitemid 44326350)
281. Röder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: A systematic review. Pediatr Allergy Immunol 2008; 19:197-207. (Pubitemid 351499173)
282. Larenas-Linnemann D. Sublingual immunotherapy in children: Complete and updated review supporting evidence of effect. Curr Opin Allergy Clin Immunol 2009; 9:168-176.
283. Calderó n MA, Penagos M, Durham SR. Sublingual immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin Allergy Immunol 2008; 21:359-375.
284. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
285. Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160-166.
286. Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-173.
287. Stelmach I, Kaluziń ska-Parzyszek I, Jerzynska J, et al. Comparative effect of precoseasonal and continuous grass sublingual immunotherapy in children. Allergy 2012; 67:312-320.
288. Pajno GB, Caminiti L, Crisafulli G, et al. Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: A randomized controlled study. Pediatr Allergy Immunol 2011; 22:803-807.
289. Sieber J, Gross A, Shah-Hosseini K, Mösges R. The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT. Asian Pac J Allergy Immunol 2010; 28:232-236.
290. Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. J Allergy Clin Immunol 2010; 126:969-975.
291. Eifan AO, Akkoc T, Yildiz A, et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/ rhinitis children sensitized to house dust mite: An open randomized controlled trial. Clin Exp Allergy 2010; 40:922-932.
292. Keles S, Karakoc-Aydiner E, Ozen A, et al. A novel approach in allergenspecific immunotherapy: Combination of sublingual and subcutaneous routes. J Allergy Clin Immunol 2011; 128:808-815.
293. Eichler I, Soriano ES. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children. Allergy 2011; 66:999-1004.
294. Matricardi PM, Kuna P, Panetta V, et al. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on metaanalyses. J Allergy Clin Immunol 2011; 128:791-799.
295. Tripodi S, Frediani T, Lucarelli S, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy. J Allergy Clin Immunol 2012; 129:834-839.
296. Valenta R, Lidholm J, Niederberger V, et al. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904. (Pubitemid 29317799)
297. Jutel M, Jaeger L, Suck R, et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116: 608-613. (Pubitemid 41267135)
298. Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130:894-901.
299. Maggi E. T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol 2010; 161:10-18.
300. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J ExpMed 2007; 204:1849-1861. (Pubitemid 47240944)
301. Cosmi L, De Palma R, Santarlasci V, et al. Human interleukin 17-producing cells originate froma CD161CD4 T cell precursor. J Exp Med 2008; 205:1903-1916.
302. Santarlasci V, Maggi L, Capone M, et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012; 36:201-214.
303. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008; 57:121-134. (Pubitemid 351897666)
304. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010; 72:495-516.
305. Al-Ramli W, Prèfontaine D, Chouiali F, et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123: 1185-1187.
306. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-692.
307. Jutel M, Pichler WJ, Skrbic D, et al. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen stimulated T cell cultures. J Immunol 1995; 154:4187-4194.
308. James LK, Durham SR. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy 2008; 38:1074-1088.
309. Maggi E, Vultaggio A, Matucci A. T-cell responses during allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol 2012; 12:1-6.
310. Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010; 125 (2 Suppl 2):S306-S313.
311. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-384.
312. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-650.
313. Filì L, Ferri S, Guarna F, et al. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. J Allergy Clin Immunol 2006; 118:511-517. (Pubitemid 44160724)
314. Vultaggio A, Nencini F, Fitch PM, et al. Modified adenine (9-benzyl-2-butoxy- 8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. J Immunol 2009; 182:880-889.
315. Vultaggio A, Nencini F, Pratesi S, et al. The TLR7 ligand 9-benzyl-2-butoxy-8- hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines. J Immunol 2011; 186:4707-4715.
316. Roitt I, Brostoff J, Male D: Immunology, 6th ed., New York: Mosby; 2001.
317. Fiocchi A, Schunemann H, Terracciano L, et al. DRACMA one year after: which changes have occurred in diagnosis and treatment of CMA in Italy? Ital J Pediatr 2011; 37:53.
318. Sladkevicius E, Guest JF. Modelling the health economic impact of managing cows milk allergy in South Africa. J Med Econ 2010; 13:257-272.
319. Sladkevicius E, Nagy E, Lack G, Guest JF. Resource implications and budget impact of managing cows milk allergy in the UK. J Med Econ 2010; 13:119-128.
320. Nowak-Wegrzyn A, Assaad AH, Bahna SL, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009; 123 (6 Suppl):S365-S383.
321. Savilahti EM, Rantanen V, Lin JS, et al. Early recovery from cows milk allergy is associated with decreasing IgE and increasing IgG4 binding to cows milk epitopes. J Allergy Clin Immunol 2010; 125:1315-1321.
322. Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food proteininduced enterocolitis syndrome. J Pediatr 1998; 133:214-219. (Pubitemid 28385197)
323. Nowak-Wegrzyn A, Muraro A. Food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2009; 9:371-377.
324. Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol 2006; 17:351-355. (Pubitemid 43989957)
325. Mehr SS, Kakakios AM, Kemp AS. Rice: A common and severe cause of food protein-induced enterocolitis syndrome. Arch Dis Child 2009; 94:220-223.
326. Hojsak I, Kljaić -Turkalj M, Misak Z, Kolacek S. Rice protein-induced enterocolitis syndrome. Clin Nutr 2006; 25:533-536. (Pubitemid 43843027)
327. Kelly KJ, Lazenby AJ, Rowe PC. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology 1995; 109:1503-1512.
328. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: Clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48:30-36.
329. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4:1097-1102. (Pubitemid 44311644)
330. Aceves SS, Bastian JF, Newbury RO, Dohil R. Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007; 102:2271-2279. (Pubitemid 47493832)
331. Assaad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: An 8-year follow-up. J Allergy Clin Immunol 2007; 119:731-738. (Pubitemid 46335818)
332. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131:1381-1391. (Pubitemid 44780861)
333. Assaad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 2011; 141:1593-1604.
334. Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129:456-463.
335. Chapman JA, Bernstein IL, Lee RE, et al. Food allergy: A practice parameter. Ann Allergy Asthma Immunol 2006; 96 (Suppl 3):1-68.
336. Fiocchi A. Incremental prognostic factors associated with cows milk allergy outcomes in infant and child referrals: The Milan Cows Milk Allergy Cohort study. Ann Allergy Asthma Immunol 2008; 101:166-173.
337. Skripak JM. Mammalian milk allergy: Avoidance strategies and oral desensitization. Curr Opin Allergy Clin Immunol 2009; 9:259-264.
338. Nowak-Wegrzyn A. Tolerance to extensively heated milk in children with cows milk allergy. J Allergy Clin Immunol 2008; 122:342-347.
339. Vanto T, Helppila S, Juntunen-Backman K, et al. Prediction of the development of tolerance to milk in children with cows milk hypersensitivity. J Pediatr 2004; 144:218-222. (Pubitemid 38869398)
340. Shek LP, Soderstrom L, Ahlsdedt S, et al. Determination of food specific IgE levels over time can predict the development of tolerance in cows milk and hens egg allergy. J Allergy Clin Immunol 2004; 114:387-391. (Pubitemid 39119042)
341. Kim JS, Sicherer S. Should avoidance of foods be strict in prevention and treatment of food allergy? Curr Opin Allergy Clin Immunol 2010; 10:252-257.
342. Lemon-Mule H. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008; 122:977-983.
343. Barbi E, Gerarduzzi T, Longo G, Ventura A. Fatal allergy as a possible consequence of long-term elimination diet. Allergy 2004; 59:668-669. (Pubitemid 38748068)
344. Flinterman AE. Acute allergic reactions in children with AEDS after prolonged cows milk elimination diets. Allergy 2006; 61:370-374. (Pubitemid 43381815)
345. Skripak JM. The natural history of IgE-mediated cows milk allergy. J Allergy Clin Immunol 2007; 120:1172-1177. (Pubitemid 350029907)
346. Prescott SL, Bouygue GR, Videky D, Fiocchi A. Avoidance or exposure to foods in prevention and treatment of food allergy? Curr Opin Allergy Clin Immunol 2010; 10:258-266.
347. Kim JS. Dietary baked milk accelerates the resolution of cows milk allergy in children. J Allergy Clin Immunol 2011; 128:125-131.
348. Terracciano L. Impact of dietary regimen on the duration of cows milk allergy. Cin Experim Allergy 2010; 40:125-129.
349. Illi S, von Mutius E, Lau S, et al., Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113:925-931. (Pubitemid 38608603)
350. Kurukulaaratchy RJ, Matthews S, Arshad SH. Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease. Allergy 2005; 60:1280-1286. (Pubitemid 41297525)
351. Lemon-MulèH, Sampson HA, Sicherer SH, et al. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008; 122:977-983.
352. Fiocchi A, Bouygue GR, Sarratud T, et al. Clinical tolerance of processed foods. Ann Allergy Asthma Immunol 2004; 93:S38-S46. (Pubitemid 39507702)
353. Restani P, Ballabio C, Di Lorenzo C, et al. Molecular aspects of milk allergens and their role in clinical events. Anal Bioanal Chem 2009; 395:47-56.
354. Hill DJ, Firer MA, Ball G, Hosking CS. Natural history of cows milk allergy in children: Immunological outcome over 2 years. Clin Exp Allergy 1993; 23:124-131. (Pubitemid 23070560)
355. Saarinen KM, Pelkonen AS, MäkeläMJ, Savilahti E. Clinical course and prognosis of cows milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol 2005; 116:869-875. (Pubitemid 41400554)
356. Boyano-Martinez T, Garcia-Ara C, Pedrosa M, et al. Accidental allergic reactions in children allergic to cows milk proteins. J Allergy Clin Immunol 2009; 123:883-888.
357. Meglio P, Bartone E, Plantamura M, et al. A protocol for oral desensitization in children with IgE-mediated cows milk allergy. Allergy 2004; 59:980-987. (Pubitemid 39141411)
358. Patriarca C, Romano A, Venuti A, et al. Oral specific hyposensitization in the management of patients allergic to food. Allergol et Immunopathol (Madr) 1984; 12:275-281. (Pubitemid 14011801)
359. Patriarca G, Buonomo A, Roncallo C, et al. Oral desensitisation in cows milk allergy: Immunological findings. Int J Immunopathol Pharmacol 2002; 15:53-58. (Pubitemid 34285709)
360. Patriarca G, Schiavino D, Nucera E, et al. Food allergy in children: Results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998; 45:52-58. (Pubitemid 28067527)
361. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cows milk allergy: A systematic review and meta-analysis. Clin Exp Allergy 2012; 42:363-374.
362. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cows milk-induced reactions. J Allergy Clin Immunol 2008; 121:343-347.
363. Martorell A, De la Hoz B, Ibáñez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cows milk allergy. Clin Exp Allergy 2011; 41:1297-1304.
364. Morisset M, Moneret-Vautrin DA, Guenard L, et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cows milk allergy and
365. children with egg allergy. Eur Ann Allergy Clin Immunol 2007; 39:12-19.
366. Paassilta M, Salmivesi S, Korppi M, Makela M. Milk oral immunotherapy in school-aged children with immunoglobulin e-mediated cows milk allergy. Allergy 2010; 65:370.
367. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow milk allergy with a weekly up-dosing regimen: A randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010; 105:376-381.
368. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebocontrolled study of milk oral immunotherapy for cows milk allergy. J Allergy Clin Immunol 2008; 122:1154-1160.
369. Patriarca G, Nucera E, Pollastrini E, et al. Oral specific desensitization in food-allergic children. Dig Dis Sci 2007; 52:1662-1672. (Pubitemid 46870557)
370. Reche M, Valbuena T, Fiandor A, et al. Early induction of oral tolerance protocol (OTI) in children with cows milk allergy. J Allergy Clin Immunol 2011; 127:AB24.
371. Rodriguez-Alvarez M, Fernandez Rivas M, Vazquez-Cortes S, et al. Follow up of desensitised patients and immunological changes after specific oral tolerance induction to milk. Allergy 2009; 64:481-482.
372. Gerrard JW, Geddes CA, Reggin PL, et al. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976; 37:91-100.
373. Strachan DP. Hay fever, hygiene and household size. BMJ 1989; 299:1259-1260. (Pubitemid 19280051)
374. Strachan DP. Family size, infection and atopy: The first decade of the hygiene hypothesis. Thorax 2000; 55 (Suppl 1):S2-S10. (Pubitemid 30468238)
375. Rook GA. Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis 2011; 29:144-153.
376. Noverr MC, Falkowski NR, McDonald RA, et al. The development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: Role of host genetics, antigen and IL-13. Infect Immun 2005; 73:30-38. (Pubitemid 40041094)
377. Noverr MC, Huffnagle GB. The microflora hypothesis of allergic diseases. Clin Exp Allergy 2005; 35:1511-1520.
378. Tannock GW. Commentary: Remembrance of microbes past. Int J Epidemiol 2005; 34:13-15. (Pubitemid 40347361)
379. Ly NP, Litonjua A, Gold DR, Celedó n JC. Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol 2011; 127:1087-1094.
380. Adlerberth I, Strachan DP, Matricardi PM, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120:343-350. (Pubitemid 47102389)
381. Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food.Guidelines for the evaluation of probiotics in food: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, April 30 and May 1, 2002. http:// www.who.int/foodsafety/fs-management/en/probiotic-guidelines.pdf
382. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: Review of the theoretical background and clinical evidence. Pediatr Allergy Immunol 2010; 21:e355-e367.
383. Braegger C, Chmielewska A, Decsi T, et al., ESPGHAN Committee on Nutrition. Supplementation of infant formula with probiotics and/or prebiotics: A systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52:238-250.
384. Fiocchi A, Burks W, Bahna SL, et al.; on behalf of the WAO Special Committee on Food Allergy and Nutrition. Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J 2012; 5:148-167.
385. Kuitunen M, Savilahti E, Sarnesto A. Human alpha-lactalbumin and bovine beta-lactoglobulin absorption in infants. Allergy 1994; 49:354-360.
386. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr 2010; 156:S8-S15.
387. Sansonetti PJ, Medzhitov R. Learning tolerance while fighting ignorance . Cell 2009; 138:416-420.
388. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-1745. (Pubitemid 127484159)
389. Kalliomäki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-134. (Pubitemid 32105256)
390. Björkstén B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516-520. (Pubitemid 32978019)
391. Snydman DR. The safety of probiotics. Clin Infect Dis 2008; 46 (Suppl 2):S104-S111. (Pubitemid 351323676)
392. Hammerman C, Bin-Nun A, Kaplan M. Safety of probiotics: Comparison of two popular strains. BMJ 2006; 333:1006-1008. (Pubitemid 44764349)
393. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122:8-12.
394. Schabussova I, Wiedermann U. Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Curr Opin Allergy Clin Immunol 2008; 8:557-564.
395. Savilahti E, Kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008; 8:243-248.
396. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357:1076-1079. (Pubitemid 32322538)
397. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: A randomized, doubleblind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-198. (Pubitemid 46037805)
398. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebocontrolled trial. J Allergy Clin Immunol 2008; 122:788-794.
399. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121:e850-e856.
400. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174-1180. (Pubitemid 46654165)
401. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-191. (Pubitemid 46037800)
402. Prescott SL, Wiltschut J, Taylor A, et al. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63:1481-1490.
403. Soh SE, Aw M, Gerez I, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants: effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39:571-578.
404. Bottcher MF, Abrahamsson TR, Fredriksson M, et al. Low breast milk TGFbeta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2008; 19:497-504.
405. Prescott SL, Wickens K, Westcott L, et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factorbeta and immunoglobin A detection. Clin Exp Allergy 2008; 38:1606-1614.
406. Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: A randomized controlled trial. Allergy 2011; 66:509-516.
407. Kuitunen M, Kukkonen A, Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol 2012; 159:162-170.
408. Niers L, Martiǹ R, Rijkers G, et al. The effects of selected probiotic strains on the development of eczema (the P and A study). Allergy 2009; 64:1349-1358.
409. Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21:e386-e393.
410. West CE, Hammarström ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20:430-437.
411. Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: A randomized, double-blind trial. Br J Dermatol 2010; 163:616-623.
412. Huurre A, Laitinen K, Rautava S, et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: A double-blind placebo-controlled study. Clin Exp Allergy 2008; 38:1342-1348. (Pubitemid 352019662)
413. Kalliomäki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-1871. (Pubitemid 36645184)
414. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1019-1021. (Pubitemid 46527807)
415. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgEassociated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123:335-341.
416. Wickens K, Black P, Stanley T, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42:1071-1079.
417. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007:CD006475.
418. Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: Clinical effects in allergic disease. Curr Opin Pediatr 2010; 22:626-634.
419. Ege MJ, Bieli C, Frei R, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006; 117:817-823.
420. Marschan E, Kuitunen M, Kukkonen K, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38:611-618. (Pubitemid 351406072)
421. Ozdemir O. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin Exp Immunol 2010; 160:295-304.
422. Saxelin M, Lassig A, Karjalainen H, et al. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol 2010; 144:293-300.
423. Donaldson VH, Evans RR. A biochemical abnormality in herediatry angioneurotic edema: Absence of serum inhibitor of C 1-esterase. Am J Med 1963; 35:37-44.
424. Bork K. Hereditary angioedema with normal c1 inhibition. Curr Allergy Asthma Rep 2009; 9:280-285.
425. Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 2012; 379:474-481.
426. Cugno M, Zanichelli A, Foieni F, et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009; 15:69-78.
427. Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group. Allergy 2012; 67:147-157.
428. Farkas H, Varga L, Szèplaki G, et al. Management of hereditary angioedema in pediatric patients. Pediatrics 2007; 120:e713-e722. (Pubitemid 47358332)
429. Lyseng-Williamson KA. Nanofiltered human C1 inhibitor concentrate (Cinryze1): In hereditary angioedema. BioDrugs 2011; 25:317-327.
430. Kreuz W, Rusicke E, Martinez-Saguer I, et al. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion 2012; 52:100-107.